Literature DB >> 12039124

Postherpetic neuralgia after shingles: an under-recognized cause of chronic vulvar pain.

Anne Louise Oaklander1, Julia G Rissmiller.   

Abstract

BACKGROUND: Vulvar shingles, an uncommon presentation of a common disease, probably affects 1.5 million American women during their lifetime and leaves about 150,000 with postherpetic neuralgia, a chronic neuropathic pain syndrome. Prompt diagnosis and treatment can minimize pain severity and duration. CASES: The case of an 88-year-old woman with sacral shingles is described. Complications led to her demise. A 35-year-old with a 6-year history of disabling vulvar pain and many diagnostic procedures was ultimately diagnosed with postherpetic neuralgia.
CONCLUSION: Shingles needs to be included in the differential diagnosis of vulvar rashes because it is a modifiable risk factor for chronic vulvar pain. The possibility of postherpetic neuralgia must be considered in women with unexplained vulvar dysesthesia.

Entities:  

Mesh:

Year:  2002        PMID: 12039124     DOI: 10.1016/s0029-7844(01)01663-5

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  4 in total

1.  A not so simplex case of genital herpes.

Authors:  K E J Philip; A Goodman; S N S Pallawela; L Sathia; D P Webster
Journal:  BMJ Case Rep       Date:  2013-10-04

2.  Evidence of small-fiber neuropathy (SFN) in two patients with unexplained genital sensory loss and sensory urinary cystopathy.

Authors:  Mahmoud A AbdelRazek; Bart Chwalisz; Anne Louise Oaklander; Nagagopal Venna
Journal:  J Neurol Sci       Date:  2017-07-09       Impact factor: 3.181

3.  Pharmacological treatment of neuropathic pain in older persons.

Authors:  Clair Haslam; Turo Nurmikko
Journal:  Clin Interv Aging       Date:  2008       Impact factor: 4.458

4.  Gastrin-releasing peptide-expressing nerves comprise subsets of human cutaneous Aδ and C fibers that may sense pruritus.

Authors:  Theresa R Timmes; Robert Rothbaum; Claudine Y Silva; Jag Bhawan; Deborah L Cummins; Deon Wolpowitz
Journal:  J Invest Dermatol       Date:  2013-04-23       Impact factor: 8.551

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.